Literature DB >> 1005044

Remote prognosis after eclampsia.

L C Chesley.   

Abstract

Of 270 women who survived eclampsia in the period 1931 through 1951, all but three were traced in 1974. In white women having eclampsia as primiparas, neither the remote mortality nor the prevalence of hypertension is increased over that in unselected women matched for age. Both are increased significantly in white women having eclampsia as multiparas and in the 24 black women in the study. The excess of remote deaths among the multiparous eclamptic women is accounted for by the lethal consequences of hypertensive disease. Repeated hypertensive pregnancies after eclampsia are often a sign of latent essential hypertension and may precipitate prematurely a chronic hypertension that is in the making. The prevalence of diabetes of late onset is increased over the expected rate in both primiparous and multiparous eclamptic women. It is concluded that eclampsia is neither a sign of latent hypertensive nor of renal disease, and it does not cause chronic hypertension, whatever the duration of the acute hypertensive phase.

Entities:  

Mesh:

Year:  1976        PMID: 1005044

Source DB:  PubMed          Journal:  Perspect Nephrol Hypertens        ISSN: 0092-2900


  4 in total

Review 1.  Preeclampsia and diabetes.

Authors:  Tracey L Weissgerber; Lanay M Mudd
Journal:  Curr Diab Rep       Date:  2015-03       Impact factor: 4.810

2.  Sympathetic responsiveness is not increased in women with a history of hypertensive pregnancy.

Authors:  Sushant M Ranadive; Ronee E Harvey; Brian D Lahr; Virginia M Miller; Michael J Joyner; Jill N Barnes
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2016-12-07       Impact factor: 3.619

Review 3.  Cardiovascular System in Preeclampsia and Beyond.

Authors:  Basky Thilaganathan; Erkan Kalafat
Journal:  Hypertension       Date:  2019-03       Impact factor: 10.190

4.  Cardiovascular mortality after pre-eclampsia in one child mothers: prospective, population based cohort study.

Authors:  Rolv Skjaerven; Allen J Wilcox; Kari Klungsøyr; Lorentz M Irgens; Bjørn Egil Vikse; Lars J Vatten; Rolv Terje Lie
Journal:  BMJ       Date:  2012-11-27
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.